Depression Clinical Trials in Houston, TX

49 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	<1 mi
Intracranial Investigation of Neural Circuity Underlying Human Mood	N/A	Baylor College of Medicine	<1 mi
Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)	N/A	Joao L. DeQuevedo	<1 mi
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression	Phase 1	The University of Texas Health Science Center, Houston	<1 mi
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression	N/A	The University of Texas Health Science Center, Houston	<1 mi
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia	N/A	The University of Texas Health Science Center, Houston	<1 mi
Improving Behavioral Health for Caregivers and Children After Pediatric Injury	N/A	Medical University of South Carolina	<1 mi
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia	N/A	GrayMatters Health Ltd.	<1 mi
DBS for Depression	N/A	Baylor College of Medicine	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression	N/A	VA Office of Research and Development	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors	N/A	The University of Texas Health Science Center, Houston	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality	Phase 2	The University of Texas Health Science Center, Houston	<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	<1 mi
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression	N/A	Wayne Goodman MD	<1 mi
Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing	N/A	Baylor College of Medicine	<1 mi
Transcutaneous Vagus Nerve Stimulation for Attention and Memory	N/A	Baylor College of Medicine	<1 mi
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users	N/A	Baylor College of Medicine	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder	N/A	The University of Texas Health Science Center, Houston	<1 mi
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV	Phase 2	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)	N/A	Baylor College of Medicine	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Telehealth Behavioral Activation for Teens	N/A	Baylor College of Medicine	<1 mi
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy	Phase 2	M.D. Anderson Cancer Center	<1 mi
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer	Phase 2/3	M.D. Anderson Cancer Center	<1 mi
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors	Phase 2	M.D. Anderson Cancer Center	<1 mi
Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus	N/A	Christina Chianis Reed	<1 mi
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story	—	Baylor College of Medicine	<1 mi
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity	N/A	Deliberate Solutions Inc.	<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	7 mi
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study	Phase 3	Yale University	7 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	7 mi
The OBSERVE Protocol	—	Yale University	7 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	14 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	19 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	20 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	20 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.